Holen Sie sich die Stockscreener-App
3.02
5.03%
-0.16
Ispecimen Inc Aktie (ISPC) Neueste Nachrichten
iSpecimen (NASDAQ: ISPC) registers 488,290 shares from May 2026 placement - Stock Titan
MSN Money - MSN
$iSpecimen (ISPC.US)$ so far so good - Moomoo
iSpecimen Receives Nasdaq Noncompliance Notice, Listing at Risk - The Globe and Mail
iSpecimen Inc. Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Emerging Growth Status (May 29, 2026) - Minichart
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (NASDAQ: ISPC) falls below Nasdaq equity listing requirement - Stock Titan
iSpecimen Inc. Files Form 8-K Announcing Approval of 2025 Stock Incentive Plan and Key Company Details - Minichart
What's Driving iSpecimen's Recent Stock Surge - Kavout
iSpecimen Shareholders Approve Director, Auditor and Incentive Plan - TipRanks
iSpecimen (ISPC) investors approve director, auditor and 2025 stock incentive plan - Stock Titan
iSpecimen trades near lows as cash test and vote loom - Bez Kabli
iSpecimen Inc. (ISPC) Holds Steady Near Key Support as Sector Headwinds LingerMean Reversion Trade - thelegaladvocate.com
iSpecimen Inc. (ISPC) Slips 2% as Stock Tests Support Near $3.21Swing Trade Setups - newsline.com
iSpecimen Inc (ISPC) Stock Price, Quote, News & History - Benzinga
iSpecimen (ISPC) Q3 2024 Earnings: Disappointing Bottom Line Sends Shares LowerDownward Estimate Revision - newsline.com
iSpecimen stock (US46536T1016): Company update still needs a dated catalyst - AD HOC NEWS
iSpecimen Inc stock (US46536T1016): Clinical sample platform faces a fresh investor spotlight - AD HOC NEWS
iSpecimen Inc. Q1 2026 10-Q Report: Financial Performance, Going Concern, and Reverse Stock Split Overview - Minichart
iSpecimen Inc. 1Q 2026: Revenue $156.01K, EPS ($6.66) — 10-Q Summary - TradingView
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
What is iSpecimen Inc. stock? - Bitget
iSpecimen (NASDAQ: ISPC) posts Q1 2026 loss and warns of going-concern risk - Stock Titan
iSpecimen (NASDAQ: ISPC) notifies SEC of late 10-Q filing - Stock Titan
ISPC Should I Buy - Intellectia AI
iSpecimen stock (US46536T1016): capital raise and Nasdaq compliance in focus - AD HOC NEWS
iSpecimen Inc. Announces $2.5 Million Private Placement to Support Marketplace Growth and Marketing Efforts - Minichart
iSpecimen Regains Nasdaq Compliance and Raises New Capital - TipRanks
iSpecimen Raises ~$2.5 Million via Private Placement of Stock and Pre-Funded Warrants - TradingView
iSpecimen (Nasdaq: ISPC) prices $2.5M private placement and regains Nasdaq bid compliance - Stock Titan
iSpecimen raises $2.5M in private placement via E.F. Hutton By Investing.com - Investing.com Australia
iSpecimen raises $2.5M in private placement via E.F. Hutton - Investing.com
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement - The Manila Times
E.F. Hutton Secures $2.5 Million for iSpecimen - Intellectia AI
TradingKey - TradingKey
iSpecimen announces pricing of approximately $2.5M private placement - MSN
ISpecimen Inc. announced that it has received $2.500004 million in funding - marketscreener.com
iSpecimen prices $2.5M private placement at $5.12 per share By Investing.com - Investing.com Australia
iSpecimen Completes $2.5 Million Private Placement - Intellectia AI
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement - Taiwan News
ISPCiSpecimen Inc. stock news, filings & ratings - Quantisnow
In $2.5M financing, iSpecimen earmarks up to $900,000 for marketing - Stock Titan
iSpecimen Announces $2.5 Million Private Placement Priced at $1.10 Per Share - geneonline.com
iSpecimen prices $2.5M private placement at $5.12 per share - Investing.com
2.13%
2.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):